Kumud Kalia insider trades: Guardant Health (GH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kumud reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | GH | ↓ Sell | 4,000 | $158.05 | $632K | Direct | Sep 14, 2026 (3d) |
| Jun 15, 2026 | GH | ↓ Sell | 1,200 | $130.97 | $157K | Direct | Jun 30, 2026 (15d) |
| Jun 15, 2026 | GH | ↑ Buy | 600 | $130.76 | $78K | Direct | Jun 30, 2026 (15d) |
| Jun 11, 2026 | GH | ↓ Sell | 3,418 | $130.24 | $445K | Direct | Jun 15, 2026 (4d) |
| Jun 10, 2026 | GH | ↓ Sell | 5,000 | $130.41 | $652K | Direct | Jun 12, 2026 (2d) |
| Mar 4, 2026 | GH | ↓ Sell | 40,000 | $95.32 | $3.8M | Direct | Mar 5, 2026 (1d) |
| Dec 8, 2025 | GH | ↓ Sell | 2,000 | $104.60 | $209K | Direct | Dec 10, 2025 (2d) |
| Aug 21, 2025 | GH | ↓ Sell | 2,000 | $61.76 | $124K | Direct | Aug 22, 2025 (1d) |
| Jun 3, 2025 | GH | ↓ Sell | 4,000 | $46.39 | $186K | Direct | Jun 5, 2025 (2d) |
| Mar 17, 2025 | GH | ↓ Sell | 3,500 | $43.16 | $151K | Direct | Mar 18, 2025 (1d) |
| Nov 18, 2024 | GH | ↓ Sell | 7,000 | $29.25 | $205K | Direct | Nov 19, 2024 (1d) |
| Mar 18, 2024 | GH | ↑ Buy | 2,187 | $17.82 | $39K | Direct | Mar 19, 2024 (1d) |
| Dec 1, 2023 | GH | ↓ Sell | 5,800 | $26.37 | $153K | Direct | Dec 4, 2023 (3d) |
| Sep 12, 2023 | GH | ↓ Sell | 2,125 | $32.59 | $69K | Direct | Sep 13, 2023 (1d) |
| Jun 9, 2023 | GH | ↑ Buy | 2,981 | $32.71 | $97K | Direct | Jun 13, 2023 (4d) |
| Mar 3, 2023 | GH | ↓ Sell | 6,500 | $31.92 | $207K | Direct | Mar 3, 2023 (0d) |
| Nov 15, 2022 | GH | ↓ Sell | 3,125 | $51.87 | $162K | Direct | Nov 17, 2022 (2d) |
| Aug 17, 2022 | GH | ↓ Sell | 2,000 | $51.39 | $103K | Direct | Aug 19, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GH insiders
Open-market trades in the last 12 months
About Kumud Kalia's insider trades
Kumud Kalia is Chief Information Officer at Guardant Health (GH). Since Aug 17, 2022, Kumud has reported 3 open-market purchases worth $215K and 15 sales worth $7.3M on SEC Form 4. In the last 12 months: 1 buy ($78K) and 6 sales ($5.9M).
Their filings also include option exercises (40 filings), shares withheld for taxes (39 filings), grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.